Twist Bioscience Corporation (BIT:1TWST)
Italy · Delayed Price · Currency is EUR 26.43
-0.89 (-3.26%)
At close: Oct 10, 2025
Twist Bioscience Cash Flow Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2016 - 2019 |
Net Income | -85.19 | -208.73 | -204.62 | -217.86 | -152.1 | -139.93 | Upgrade |
Depreciation & Amortization | 25.51 | 31.43 | 29.31 | 16.51 | 9.75 | 6.68 | Upgrade |
Stock-Based Compensation | 60.72 | 50.93 | 30.28 | 79.66 | 37 | 17.1 | Upgrade |
Other Adjustments | 2.5 | 46.86 | 3.57 | 2.66 | 2.49 | -0.92 | Upgrade |
Change in Receivables | -18.13 | 8.44 | -4.32 | -9.62 | -2.2 | -14.27 | Upgrade |
Changes in Inventories | 2.55 | 7.99 | 7.24 | -7.54 | -19.49 | -4.96 | Upgrade |
Changes in Accounts Payable | 4.74 | -11.81 | -2.51 | 7.38 | 8.54 | -5.51 | Upgrade |
Changes in Accrued Expenses | 0.97 | 12.29 | 1.48 | 7.12 | 10.51 | 1.82 | Upgrade |
Changes in Other Operating Activities | 3.11 | -1.5 | -2.9 | -2.7 | -6.74 | -2.26 | Upgrade |
Operating Cash Flow | -51.13 | -64.09 | -142.47 | -124.39 | -112.24 | -142.26 | Upgrade |
Capital Expenditures | -17.58 | -5.08 | -27.78 | -101.86 | -27.06 | -9.87 | Upgrade |
Purchases of Investments | -49.45 | -51.91 | -76.35 | -217.64 | -58.8 | -202.88 | Upgrade |
Proceeds from Sale of Investments | - | 53.91 | 154.74 | 100.48 | 242.49 | 98.1 | Upgrade |
Payments for Business Acquisitions | - | - | - | -8.16 | -0.48 | - | Upgrade |
Other Investing Activities | - | - | - | -5.76 | - | - | Upgrade |
Investing Cash Flow | -13.64 | -3.07 | 50.61 | -232.93 | 156.16 | -114.65 | Upgrade |
Long-Term Debt Repaid | - | - | - | -1.56 | -3.33 | -3.33 | Upgrade |
Net Long-Term Debt Issued (Repaid) | - | - | - | -1.56 | -3.33 | -3.33 | Upgrade |
Issuance of Common Stock | 7.47 | 10.87 | 5.32 | 279.85 | 343.36 | 309.49 | Upgrade |
Repurchase of Common Stock | -0.02 | -3.98 | -4.41 | -7.75 | -10.85 | -2.42 | Upgrade |
Net Common Stock Issued (Repurchased) | 7.45 | 6.89 | 0.91 | 272.09 | 332.52 | 307.07 | Upgrade |
Financing Cash Flow | 26.59 | 6.89 | 0.91 | 270.53 | 329.18 | 303.73 | Upgrade |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 0.05 | 0.13 | -0.03 | -0.32 | 0.02 | 0.02 | Upgrade |
Net Cash Flow | -38.13 | -60.15 | -90.98 | -87.1 | 373.11 | 46.85 | Upgrade |
Beginning Cash & Cash Equivalents | 242.04 | 578.56 | 760.52 | 934.72 | 188.49 | 94.8 | Upgrade |
Ending Cash & Cash Equivalents | 203.91 | 229.13 | 289.28 | 380.26 | 467.36 | 94.25 | Upgrade |
Free Cash Flow | -68.71 | -69.17 | -170.25 | -226.24 | -139.31 | -152.12 | Upgrade |
FCF Margin | -18.97% | -22.10% | -69.46% | -111.14% | -105.27% | -168.84% | Upgrade |
Free Cash Flow Per Share | -1.15 | -1.19 | -2.99 | -4.20 | -2.89 | -3.88 | Upgrade |
Levered Free Cash Flow | -65.9 | -175.4 | -199.78 | -300.5 | -179.92 | -157.36 | Upgrade |
Unlevered Free Cash Flow | -122.67 | -186.9 | -211.08 | -326.66 | -179.16 | -153.79 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.